Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0001846487-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-20 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $78.02 | -5,323 | 84.8K | -6% | -$415.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | S | D | 5,323 | $78.02 | 84,840 | D | — | — | (F2) The shares were sold in multiple trades at prices ranging from $77.20 to $78.58. The price reported above reflects the weighted average sales price. |